Cannabidiol Inhibits In Vitro Human Liver Microsomal Metabolism of Remdesivir: A Promising Adjuvant for COVID-19 Treatment
Author:
Affiliation:
1. College of Pharmacy and Health Sciences, St. John's University, Queens, New York, USA.
Publisher
Mary Ann Liebert Inc
Subject
Pharmacology (medical),Complementary and alternative medicine,Pharmacology
Link
https://www.liebertpub.com/doi/pdf/10.1089/can.2021.0109
Reference44 articles.
1. 1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. WHO: Geneva, 2021.
2. Remdesivir for the treatment of Covid-19: the value of biochemical studies
3. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
4. ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential
5. Pharmacokinetics and tissue distribution of remdesivir and its metabolites nucleotide monophosphate, nucleotide triphosphate, and nucleoside in mice
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Therapeutic Effects of Cannabinoids and Their Applications in COVID-19 Treatment;Life;2022-12-15
2. Cannabinoids as Emergent Therapy Against COVID-19;Cannabis and Cannabinoid Research;2022-10-01
3. In vitro evaluation of the impact of Covid-19 therapeutic agents on the hydrolysis of the antiviral prodrug remdesivir;Chemico-Biological Interactions;2022-09
4. Cannabidiol and SARS-CoV-2 Infection;Frontiers in Immunology;2022-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3